Adawi Kamal bought FATE
January 15, 2026 · Form 4 insider transaction
Adawi Kamal bought 75,000 shares of Fate Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
75,000
Price
$0.00
Total value
N/A
InsiderAdawi Kamal
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 15, 2026
Filing dateJanuary 16, 2026
Shares owned after75,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to this option shall vest in 36 equal monthly installments following January 1, 2026, such that all of the shares shall be fully vested and exercisable on January 1, 2029, subject to the Reporting Person's continued service with the Issuer as of each such vesting date.